The effect of synthetic surfactant Exosurf on gene transfer in mouse lung in vivo

Gene Therapy

Volumn 5, Issue 10, 1998, Pages 1333-1339

  Raczka, E ^a   Kukowska Latallo, J F ^b   Rymaszewski, M ^b   Chen, C ^b   Baker Jr , J R ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Exosurf; Gene delivery; Lung; Surfactant; Transfection

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DIOLEOYLPHOSPHATIDYLCHOLINE; LUCIFERASE; LUNG SURFACTANT; PLASMID DNA; TYLOXAPOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHUS; CONTROLLED STUDY; DNA TRANSFECTION; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE;

EID: 0031728309     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300752     Document Type: Article

References (33)

1. Halley DJJ et al. The cystic fibrosis defect approached from different angles: new perspectives on the gene, the chloride channel, diagnosis and therapy. Eur J Pediatr 1990; 149: 670-677.
2. Colledge WH. Cystic fibrosis gene therapy. Curr Opin Genet Dev 1994; 4: 466-471.
3. Gao L et al. Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes. Hum Gene Ther 1993; 4: 17-24.
4. Grubb BR et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 1994; 371: 802-806.
5. Mastrangeli A et al. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J Clin Invest 1993; 91: 225-234
6. Rosenfeld MA et al. Adenovirus-mediated transfer of a recombi- nant α1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431-434.
7. Yei S et al. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration in the lung. Gene Therapy 1994; 1: 192-200.
8. Zabner J et al. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet 1994; 6: 75-83.
9. Brigham KL et al. Rapid communication: in vivo transfection of murine lungs with a functioning procaryotic gene using a liposome vehicle. Am J Med Sci 1989; 296: 278-281.
10. Canonico AE, Conary JT, Meyrick BO, Brigham KL. Aerosol and intravenous transfection of human α1-antitrypsin gene to lungs of rabbits. Am J Resp Cell Mol Biol 1994; 10: 24-29.
11. Hazinski TA, Ladd PA, DeMatteo CA. Localization and induced expression of fusion genes in the rat lung. Am J Resp Cell Mol Biol 1991; 4: 206-209.
12. Stribling R et al. Aerosol gene delivery in vivo. Proc Natl Acad Sci USA 1992; 89: 11277-11281.
13. Yoshimura K et al. Expression of human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res 1992; 20: 3233-3240.
14. Tsan M-FT, White JE, Shephard B. Lung-specific direct in vivo gene transfer with recombinant plasmid DNA. Am J Physiol 1995; 268: L1052-L1056.
15. Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 1994; 7: 362-369.
16. Ginsberg HS et at. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 1991; 88: 1651-1655.
17. Wheeler CJ et al. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci USA 1996; 93: 11454-11459.
18. Lee RJ, Huang L. Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carr Sys 1997; 14: 173-206.
19. Behr JP. Synthetic gene transfer vectors. Acc Chem Res 1993; 26: 274-278.
20. Jobe AH et al. Surfactant enhances adenovirus-mediated gene expression in rabbit lungs. Gene Therapy 1996; 3: 775-779.
21. Katkin JP, Husser RC, Langsten C, Welty SE. Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Hum Gene Ther 1997; 8: 171-176.
22. Ghio AJ, Fracica PJ, Young SL, Piantadosi CA. Synthetic surfactant scavenges oxidants and protects against hyperoxic lung injury. J Appl Physiol 1994; 77: 1217-1223.
23. Halliday HL. Natural versus synthetic surfactants in neonatal respiratory distress syndrome. Drugs 1996; 51: 226-237.
24. Davis JM et al. Short-term distribution kinetics of intratracheally administered exogenous lung surfactant. Pediatr Res 1992; 31: 445-450.
25. Corcoran JD et al. Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits. Arch Dis Child Fetal Neonatal Ed 1994; 71: F165-F169.
26. Snouwaert JN et al. An animal model for cystic fibrosis made by gene targeting. Science 1992; 257: 1083-1088.
27. Zeiher BG et al. A mouse model for the AF508 allele of cystic fibrosis. J Clin Invest 1995; 6: 2051-2064.
28. Colledge WH et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model. Nat Genet 1995; 10: 445-452.
29. Rich DP et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 1990; 347: 358-363.
30. Hyde SC et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 1993; 362: 250-255.
31. Yew NS et al. Optimization of plasmid vectors for high-level expression in lung epithelial cells. Hum Gene Ther 1997; 8: 575-584.
32. Morton NS. Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective. Thorax. 1990; 45: 825-830.
33. Lee ER et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther 1996; 7: 1701-1717.